Understanding and addressing cardiovascular disease (CVD) risk has implications for maternal and child health outcomes. Heart age, the modeled age of an individual's cardiovascular system based on risk level, and excess heart age, the difference between a person's heart age and chronological age, are alternative simplified ways to communicate CVD risk. Among women with a recent live birth, we predicted heart age, calculated prevalence of excess heart age (≥5 years), and examined factors associated with excess heart age.
Materials and Methods:
Data were analyzed in 2017 from 2009 to 2014 Pregnancy Risk Assessment Monitoring System (PRAMS). To calculate heart age we used maternal age, prepregnancy body mass index, systolic blood pressure, smoking status, and diabetic status. Weighted prevalence and prevalence ratios compared the likelihood of excess heart age across racial/ethnic groups by selected factors.
Results:
Prevalence of excess heart age was higher in non-Hispanic black women (11.8%) than non-Hispanic white women (7.3%, prevalence ratio [PR], 95% confidence interval [CI]: 1.62, 1.49–1.76) and Hispanic women (4.9%, PR, 95% CI: 2.39, 2.10–2.72). Prevalence of excess heart age was highest among women who were without health insurance, obese or overweight, engaged in physical activity less than thrice per week, or were smokers in the prepregnancy period. Among women with less than high school education, non-Hispanic black women had a higher prevalence of excess heart age than Hispanic women (PR, 95% CI: 4.01, 3.15–5.10).
Conclusions:
Excess heart age may be an important tool for decreasing disparities and encouraging CVD risk reduction among certain groups of women.
Get full access to this article
View all access options for this article.
References
1.
BenjaminEJ, BlahaMJ, ChiuveSE, et al.Heart disease and stroke statistics-2017 update: A report from the American Heart Association. Circulation, 2017; 135:e146–e603.
2.
GoAS, MozaffarianD, RogerVL, et al.Heart disease and stroke statistics-2014 update: A report from the American Heart Association. Circulation, 2014; 129:e28–e292.
3.
MozaffarianD, BenjaminEJ, GoAS, et al.Heart disease and stroke statistics-2016 update: A report from the American Heart Association. Circulation, 2016; 133:e38–e360.
4.
BrownMC, BestKE, PearceMS, WaughJ, RobsonSC, BellR. Cardiovascular disease risk in women with pre-eclampsia: Systematic review and meta-analysis. Eur J Epidemiol, 2013; 28:1–19.
5.
CallaghanWM, CreangaAA, KuklinaEV. Severe maternal morbidity among delivery and postpartum hospitalizations in the United States. Obstet Gynecol, 2012; 120:1029–1036.
6.
GhulmiyyahL, SibaiB. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol, 2012; 36:56–59.
7.
LisonkovaS, SabrY, MayerC, YoungC, SkollA, JosephKS. Maternal morbidity associated with early-onset and late-onset preeclampsia. Obstet Gynecol, 2014; 124:771–781.
8.
KuklinaEV, AyalaC, CallaghanWM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol, 2009; 113:1299–1306.
9.
Building U.S. Capacity to review and prevent maternal deaths. Report from nine maternal mortality review committees, 2018.
10.
BramhamK, ParnellB, Nelson-PiercyC, SeedPT, PostonL, ChappellLC. Chronic hypertension and pregnancy outcomes: Systematic review and meta-analysis. BMJ, 2014; 348:1–20.
YeeLM, CaugheyAB, ChengYW. Association between gestational weight gain and perinatal outcomes in women with chronic hypertension. Am J Obstet Gynecol, 2017; 217:348.e341–348.e349.
13.
PostonL, CaleyachettyR, CnattingiusS, et al.Preconceptual and maternal obesity: Epidemiology and health consequences. Lancet Diabetes Endocrinol, 2016; 4:1025–1036.
14.
KimSS, ZhuY, GrantzKL, et al.Obstetric and neonatal risks among obese women without chronic disease. Obstet Gynecol, 2016; 128:104–112.
15.
VinturacheA, MoledinaN, McDonaldS, SlaterD, ToughS. Pre-pregnancy body mass index (BMI) and delivery outcomes in a Canadian population. BMC Pregnancy Childbirth, 2014; 14:422.
16.
BreetveldNM, Ghossein-DohaC, van KuijkS, et al.Cardiovascular disease risk is only elevated in hypertensive, formerly preeclamptic women. BJOG Int J Obstet Gynaecol, 2014; 122:1092–1100.
17.
BhasinP, KapoorS. Pregnancy complications and calculated cardiovascular risk in urban women: Do we envisage an association?. J Urban Health, 2013; 91:162–175.
18.
HermesW, TamsmaJT, GrootendorstDC, et al.Cardiovascular risk estimation in women with a history of hypertensive pregnancy disorders at term: A longitudinal follow-up study. BMC Pregnancy Childbirth, 2013; 13:1–11.
19.
FraserA, NelsonSM, Macdonald-WallisC, et al.Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: The avon longitudinal study of parents and children. Circulation, 2012; 125:1367–1380.
20.
D'AgostinoRB, VasanRS, PencinaMJ, et al.General cardiovascular risk profile for use in primary care: The framingham heart study. Circulation, 2008; 117:743–753.
21.
YangQ, ZhongY, RitcheyM, et al.Vital signs: Predicted heart age and racial disparities in heart age among U.S. adults at the state level. MMWR, 2015; 64:950–958.
22.
Lopez-GonzalezAA, AguiloA, FronteraM, et al.Effectiveness of the heart age tool for improving modifiable cardiovascular risk factors in a Southern European population: A randomized trial. Eur J Prev Cardiol, 2015; 22:389–396.
23.
BonnerC, BellK, JansenJ, et al.Should heart age calculators be used alongside absolute cardiovascular disease risk assessment?. BMC Cardiovasc Dis, 2018; 18:19.
24.
SouretiA, HurlingR, MurrayP, van MechelenW, CobainM. Evaluation of a cardiovascular disease risk assessment tool for the promotion of healthier lifestyles. Eur J Cardiovasc Prev Rehabil, 2010; 17:519–523.
25.
ShulmanHB, GilbertBC, MsphbrendaCG, LanskyA. The pregnancy risk assessment monitoring system (PRAMS): Current methods and evaluation of 2001 response rates. Public Health Rep, 2006; 121:74–83.
26.
Centers for Disease Control and Prevention (CDC). Methodology. CDC PRAMS. Available at: https://www.cdc.gov/prams/methodology.htm#n2 Accessed October20, 2017.
27.
World Health Organization (WHO). Obesity-preventing and managing the global epidemic: Report of a WHO consultation. Geneva Obes Res, 2000.
28.
BatemanBT, Hernandez-DiazS, HuybrechtsKF, et al.Patterns of outpatient antihypertensive medication use during pregnancy in a medicaid population. Hypertension, 2012; 60:913–920.
29.
FisherSC, Van ZutphenAR, WerlerMM, et al.Maternal antihypertensive medication use and congenital heart defects: Updated results from the national birth defects prevention study. Hypertension, 2017; 69:798–805.
30.
YangQ, ZhongY, RitcheyM, et al.Predicted 10-year risk of developing cardiovascular disease at the state level in the U.S. Am J Prev Med, 2015; 48:58–69.
31.
PetersSA, HuxleyRR, WoodwardM. Smoking as a risk factor for stroke in women compared with men: A systematic review and meta-analysis of 81 cohorts, including 3,980,359 individuals and 42,401 strokes. Stroke, 2013; 44:2821–2828.
32.
ApplemanY, van RijnBB, Ten HaafME, BoersmaE, PetersSA. Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis, 2015; 241:211–218.
33.
FisherSC, KimSY, SharmaAJ, RochatR, MorrowB. Is obesity still increasing among pregnant women? Prepregnancy obesity trends in 20 states, 2003–2009. Prev Med, 2013; 56:372–378.
34.
AlbrechtSS, KuklinaEV, BansilP, et al.Diabetes trends among delivery hospitalizations in the U.S., 1994–2004. Diabetes Care, 2010; 33:768–773.
35.
RobbinsC, BouletSL, MorganI, et al.Disparities in preconception health indicators—Behavioral risk factor surveillance system, 2013–2015, and pregnancy risk assessment monitoring system, 2013–2014. MMWR Surveill Summ, 2018; 67:1–16.
36.
HartJ, WilliamsDR. Toward health equity—The costs of U.S. health disparities. Paper presented at: Altarum institute distinguished scholars seminar; June 18, 2009; Washington, DC.
37.
MartinJA, HamiltonBE, OstermanMJ. Births in the United States, 2015. NCHS Data Brief, 2016:1–8.
38.
National Center for Health Statistics (NCHS). Final natality data. Available at: www.marchofdimes.org/peristats Accessed March21, 2018.
39.
HowellEA. Reducing disparities in severe maternal morbidity and mortality. Clin Obstet Gynecol, 2018; 61:387–399.
40.
MoaddabA, DildyGA, BrownHL, et al.Health care disparity and pregnancy-related mortality in the United States, 2005–2014. Obstet Gynecol, 2018; 131:707–712.
41.
HowellEA, EgorovaN, BalbierzA, ZeitlinJ, HebertPL. Black-white differences in severe maternal morbidity and site of care. Am J Obstet Gynecol, 2016; 214:122.e121–e127.
42.
GongoraMC, WengerNK. Cardiovascular complications of pregnancy. Int J Mol Sci, 2015; 16:23905–23928.
43.
BrownHL, WarnerJJ, GianosE, et al.Promoting risk identification and reduction of cardiovascular disease in women through collaboration with obstetricians and gynecologists: A presidential advisory from the American Heart Association and the American College of Obstetricians and Gynecologists. Circulation, 2018; 137:e843–e852.
44.
KurthT, MooreSC, GazianoJM, et al.Healthy lifestyle and the risk of stroke in women. Arch Intern Med, 2006; 166:1403–1409.
45.
RisingSS. Centering pregnancy. An interdisciplinary model of empowerment. J Nurse Midwife, 1998; 43:46–54.
46.
TongVT, DietzPM, MorrowB, et al.Trends in smoking before, during, and after pregnancy—Pregnancy risk assessment monitoring system, United States, 40 sites, 2000–2010. MMWR Surveill Summ, 2013; 62:1–19.
47.
RaikoJR, MagnussenCG, KivimakiM, et al.Cardiovascular risk scores in the prediction of subclinical atherosclerosis in young adults: Evidence from the cardiovascular risk in a young Finns study. Eur J Cardiovasc Prev Rehabil, 2010; 17:549–555.
48.
BerryJD, Lloyd-JonesDM, GarsideDB, GreenlandP. Framingham risk score and prediction of coronary heart disease death in young men. Am Heart J, 2007; 154:80–86.
49.
GorberSC, TremblayM, MoherD, GoberB. A comparison of direct vs. self-report measures for assessing height, weight and body mass index: A systematic review. Obes Rev, 2007; 8:307–326.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
